Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Signal transduction using nitric oxide and cyclic guanosine monophosphate

Article Abstract:

A winner of the 1996 Lasker awards describes his research on nitric oxide and cyclic guanosine monophosphate (GMP). He studied cyclic GMP as a second messenger, which is a chemical whose synthesis is stimulated by a hormone. Focusing on the enzyme that produces cyclic GMP, he found that many nitrogen compounds could activate the enzyme. The most likely component that could account for this was nitric oxide. Nitric oxide has been shown to be involved in many processes, including smooth muscle relaxation, platelet aggregation and neurotransmission.

Author: Murad, Ferid
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
Muscle relaxants

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide

Article Abstract:

A winner of the 1996 Lasker awards describes his research that led to the discovery of endothelium-derived relaxing factor. He used strips of rabbit aorta to test different drugs and chemicals that affect blood vessels. In one experiment, acetylcholine unexpectedly caused the strips to relax rather than contract. A substance was isolated from the endothelial cells in the strip and named endothelium-derived relaxing factor, or EDRF. There is much evidence that EDRF is nitric oxide or a very similar chemical.

Author: Furchgott, Robert F.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
Endothelium-derived relaxing factors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nitric Oxide Deficiency as a Cause of Clinical Hypertension: Promising New Drug Targets for Refractory Hypertension

Article Abstract:

Drugs that boost the production of nitric oxide may be beneficial in treating hypertension. Nitric oxide relaxes blood vessels so if it is deficient, blood vessels will constrict, thereby raising blood pressure.

Author: Thomas, Gail D., Zhang, Weiguo, Victor, Ronald G.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Hypertension, Causes of

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Physiological aspects, Nitric oxide
Similar abstracts:
  • Abstracts: Treating internal resorption using a syringeable composite resin. The new posterior resins and a simplified placement technique
  • Abstracts: Bedside diagnostic blood testing: its accuracy, rapidity, and utility in blood conservation. Diagnostic Accuracy of a Bedside D-dimer Assay and Alveolar Dead-Space Measurement for Rapid Exclusion of Pulmonary Embolism: A Multicenter Study
  • Abstracts: Killing heat. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly
  • Abstracts: Advances in medical imaging. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer
  • Abstracts: Training logic: How the science of sets, reps and rest can speed your gains in the gym. Power surge
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.